{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:48:35Z","timestamp":1777308515858,"version":"3.51.4"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,10,10]]},"DOI":"10.18632\/oncotarget.19833","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T17:39:07Z","timestamp":1501781947000},"page":"83334-83342","source":"Crossref","is-referenced-by-count":36,"title":["Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone"],"prefix":"10.18632","volume":"8","author":[{"given":"Pedro-Antonio","family":"Regidor","sequence":"first","affiliation":[{"name":"Exeltis West Europe & Germany, Ismaning, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolf E.","family":"Schindler","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Medizinische Forschung, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","article-title":"Classification and pharmacology of progestins","volume":"61","author":"Thijssen","year":"2008","journal-title":"Maturitas"},{"key":"2","first-page":"41","article-title":"Non-contraceptive benefits of oral hormonal contraceptives","volume":"11","author":"Schindler","year":"2013","journal-title":"Int J Endocrinol Metab"},{"key":"3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.contraception.2010.05.005","article-title":"Non-contraceptive health benefits of intrauterine hormonal systems","volume":"82","author":"Fraser","year":"2010","journal-title":"Contraception"},{"key":"4","unstructured":"Trussell, Card, Hogue. \u201cAdolescent Sexual Behavior, Pregnancy, and Childbearing,\u201d in R.A. Hatcher et al., Contraceptive Technology: Seventeenth Revised Edition, Irvington Publishers, New York, 1998, in press; and The Alan Guttmacher Institute (AGI), Sex and America\u2019s Teenagers, New York, 1994."},{"key":"5","volume-title":"The Best Intentions: Unintended Pregnancy and the Well-Being of Children and Families","author":"Eisenberg","year":"1995"},{"key":"6","article-title":"Procedure under Article 31 of Directive 2001\/83\/EC resulting from pharmacovigilance data","volume":"15","author":"PRAC referral assessment report","journal-title":"Combined hormonal contraceptives containing medicinal products INN: chlormadinone, desogestrel, dienogest, drospirenone, etonogestrel, gestodene, nomegestrol, norelgestromin or norgestimate. Procedure number: EMEA\/H\/A-31\/1356"},{"key":"7","unstructured":"Opinion of the Committee for Medicinal Products for Human Use pursuant to Article 31 of Directive 2001\/83\/EC for dienogest\/ethinylestradiol containing medicinal products indicated in acne. EMA\/CHMP\/562861\/2016. Committee for Medicinal Products for Human Use. EMEA\/H\/A-31\/1435. January 2017."},{"key":"8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0039-128X(92)90016-3","article-title":"Steroid research at Syntex: \u201cthe pill\u201d and cortisone","volume":"57","author":"Djerassi","year":"1992","journal-title":"Steroids"},{"key":"9","first-page":"157","article-title":"Pharmacology of Progestogens","volume":"8","author":"Kuhl","year":"2011","journal-title":"J Reproduktionsmed Endokrinol"},{"key":"10","unstructured":"Wiechert, Bittler, Kerb, Vasals-Stenzel, Losert. inventors; Bayer Pharma AG, assignee. New spirolactones and process for their preparation. Deutsches patent DE 2652761. 1978 May 18."},{"key":"11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2165\/00003495-199651020-00002","article-title":"Comparative pharmacology of newer progestogens","volume":"51","author":"Kuhl","year":"1996","journal-title":"Drugs"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Norman, Castaner, Castaner. Drospirenone. Drugs Future. 2000; 25:1247\u201356. https:\/\/doi.org\/10.1358\/dof.2000.025.12.605117.","DOI":"10.1358\/dof.2000.025.12.605117"},{"key":"13","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1210\/jcem-73-4-837","article-title":"Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women","volume":"73","author":"Heithecker","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"15","first-page":"49","article-title":"Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties","volume":"6","author":"R\u00fcbig","year":"2003","journal-title":"Climacteric"},{"key":"16","first-page":"3","article-title":"The preclinical and clinical profile of dienogest. A short overview","volume":"35","author":"Zimmermann","year":"1999","journal-title":"Drugs Today (Barc)"},{"key":"17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/13697130009167612","article-title":"Comparison of the efficacy and endometrial safety of two estradiol valerate\/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women","volume":"3","author":"Oettel","year":"2000","journal-title":"Climacteric"},{"key":"18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0378-5122(00)00112-2","article-title":"Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest - a dose-ranging study","volume":"35","author":"Oettel","year":"2000","journal-title":"Maturitas"},{"key":"19","first-page":"13","article-title":"Endometrial effects of estradiol-dienogest combinations","volume":"14","author":"R\u00f6mer","year":"2009","journal-title":"Gynaecol Forum"},{"key":"20","first-page":"127","article-title":"Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest","volume":"3","author":"Serrani","year":"2011","journal-title":"Int J Womens Health"},{"key":"21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/13625189909040810","article-title":"The efficacy and tolerability of Valette: a postmarketing surveillance study","volume":"4","author":"Hoffmann","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"22","first-page":"53","article-title":"Clinical findings with the dienogest-containing oral contraceptive Valette","volume":"35","author":"Zahradnik","year":"1999","journal-title":"Drugs Today (Barc)"},{"key":"23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1358\/mf.2002.24.10.802320","article-title":"Clinical findings with the oral contraceptive combination ethinylestradiol\/dienogest in the Czech Republic","volume":"24","author":"Zimmermann","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1358\/mf.2002.24.10.802320","article-title":"Clinical findings with the oral contraceptive combination ethinylestradiol\/dienogest in Poland","volume":"24","author":"Zimmermann","year":"2002","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00105-014-2853-9","article-title":"[Acne vulgaris]. [Article in German]","volume":"65","author":"Zouboulis","year":"2014","journal-title":"Hautarzt"},{"key":"26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.contraception.2008.10.010","article-title":"Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol\/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol\/2 mg cyproterone acetate","volume":"79","author":"Gr\u00e4ser","year":"2009","journal-title":"Contraception"},{"key":"27","first-page":"97","article-title":"The effects of the dienogest-containing oral contraceptive Valetteon skin and hair. Results of a post-marketing surveillance study","volume":"35","author":"Dietrich","year":"1999","journal-title":"Drugs Today (Barc)"},{"key":"28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jfprhc-2011-100213","article-title":"Contraceptive efficacy and tolerability of ethinylestradiol 20 \u03bcg\/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study","volume":"38","author":"Elliesen","year":"2012","journal-title":"J Fam Plann Reprod Health Care"},{"key":"29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/AOG.0b013e318187e1c5","article-title":"Treatment of acne using a 3-milligram drospirenone\/20-microgram ethinyl estradiol oral contraceptive administered in a 24\/4 regimen: a randomized controlled trial","volume":"112","author":"Korner","year":"2008","journal-title":"Obstet Gynecol"},{"key":"30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Marr","year":"2008","journal-title":"Contraception"},{"key":"31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/487143","article-title":"A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms","volume":"2013","author":"Taneepanichskul","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0031-9384(97)88991-3","article-title":"The influence of menstrual-cycle phase on the relationship between testosterone and aggression","volume":"62","author":"Swann","year":"1997","journal-title":"Physiol Behav"},{"key":"33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1517\/14656566.8.7.989","article-title":"Drospirenone: a novel progestin","volume":"8","author":"Winer","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"34","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1080\/09513590.2016.1179727","article-title":"Metabolic changes in overweight and obese women above 35 years using Ethinylestradiol\/drosperinone combined contraceptive pills: a 3-year case-control study","volume":"32","author":"Gamal","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"35","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1096\/fj.13-245415","article-title":"Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice","volume":"28","author":"Marconi","year":"2014","journal-title":"FASEB J"},{"key":"36","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: danish cohort study, 2001-9","volume":"343","author":"L\u00f8kkegaard","year":"2011","journal-title":"BMJ"},{"key":"37","doi-asserted-by":"publisher","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study","volume":"353","author":"Zureik","year":"2016","journal-title":"BMJ"},{"key":"38","doi-asserted-by":"publisher","first-page":"CD006586","DOI":"10.1002\/14651858.CD006586.pub3","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","volume":"15","author":"Helmerhorst","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"39","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1743-6109.2011.02208.x","article-title":"Conventional vs. extended-cycle oral contraceptives on the quality of sexual life: comparison between two regimens containing 3 mg drospirenone and 20 \u00b5g ethinyl estradiol","volume":"8","author":"Cianci","year":"2011","journal-title":"J Sex Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1055\/s-0034-1383297","article-title":"Progesterone in Peri- and Postmenopause: A Review","volume":"74","author":"Regidor","year":"2014","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"41","first-page":"319","article-title":"Non-contraceptive benefits of hormonal contraceptives","volume":"62","author":"Schindler","year":"2010","journal-title":"Minerva Ginecol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:22:53Z","timestamp":1589203373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.19833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":41,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2017,10,10]]}},"alternative-id":["19833","29137347"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.19833","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}